[go: up one dir, main page]

DK1248638T3 - Use of enoxaparin for the treatment of cerebral ischemia - Google Patents

Use of enoxaparin for the treatment of cerebral ischemia

Info

Publication number
DK1248638T3
DK1248638T3 DK01903859T DK01903859T DK1248638T3 DK 1248638 T3 DK1248638 T3 DK 1248638T3 DK 01903859 T DK01903859 T DK 01903859T DK 01903859 T DK01903859 T DK 01903859T DK 1248638 T3 DK1248638 T3 DK 1248638T3
Authority
DK
Denmark
Prior art keywords
enoxaparin
treatment
cerebral ischemia
ischemia
cerebral
Prior art date
Application number
DK01903859T
Other languages
Danish (da)
Inventor
Veronique Mary
Jean-Marie Stutzmann
Andre Uzan
Florence Wahl
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1248638T3 publication Critical patent/DK1248638T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01903859T 2000-01-06 2001-01-03 Use of enoxaparin for the treatment of cerebral ischemia DK1248638T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000137A FR2803522B1 (en) 2000-01-06 2000-01-06 NEW THERAPEUTIC APPLICATION OF ENOXAPARIN
PCT/FR2001/000014 WO2001049298A2 (en) 2000-01-06 2001-01-03 Novel therapeutic use of enoxaparin

Publications (1)

Publication Number Publication Date
DK1248638T3 true DK1248638T3 (en) 2007-03-19

Family

ID=8845669

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01903859T DK1248638T3 (en) 2000-01-06 2001-01-03 Use of enoxaparin for the treatment of cerebral ischemia

Country Status (30)

Country Link
EP (1) EP1248638B1 (en)
JP (1) JP2003519185A (en)
KR (1) KR20020069240A (en)
CN (1) CN1400905A (en)
AR (1) AR026804A1 (en)
AT (1) ATE344671T1 (en)
AU (1) AU784656B2 (en)
BR (1) BR0107442A (en)
CA (1) CA2396178A1 (en)
CZ (1) CZ20022303A3 (en)
DE (1) DE60124373T2 (en)
DK (1) DK1248638T3 (en)
EA (1) EA006035B1 (en)
EE (1) EE200200374A (en)
ES (1) ES2275648T3 (en)
FR (1) FR2803522B1 (en)
HK (1) HK1052649A1 (en)
HR (1) HRP20020573A2 (en)
HU (1) HUP0204040A3 (en)
IL (1) IL150477A0 (en)
MX (1) MXPA02006672A (en)
NO (1) NO20023243L (en)
NZ (1) NZ520283A (en)
PL (1) PL357192A1 (en)
PT (1) PT1248638E (en)
SK (1) SK9612002A3 (en)
UA (1) UA75587C2 (en)
WO (1) WO2001049298A2 (en)
YU (1) YU51802A (en)
ZA (1) ZA200205415B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2231358C2 (en) * 2002-06-11 2004-06-27 Научно-исследовательский институт кардиологии Томского научного центра СО РАМН Method of treating acute coronary syndrome without raising segment
AR063530A1 (en) * 2006-10-30 2009-01-28 Aventis Pharma Sa PROCEDURE FOR THE USE OF SODIUM ENOXAPARINE FOR THE PREPARATION OF A MEDICINAL PRODUCT
ITMI20091445A1 (en) * 2009-08-07 2011-02-08 Inalco S P A A Socio Unico SEMI-SYNTHETIC DERIVATIVES OF K5 POLISACCARIDE FOR THE PREVENTION AND TREATMENT OF TISSUE DAMAGE ASSOCIATED WITH ISCHEMIA AND / OR REPERFUSION

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5442594A (en) * 1992-10-13 1994-05-09 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics

Also Published As

Publication number Publication date
NO20023243D0 (en) 2002-07-04
IL150477A0 (en) 2002-12-01
JP2003519185A (en) 2003-06-17
HUP0204040A2 (en) 2003-04-28
HK1052649A1 (en) 2003-09-26
HUP0204040A3 (en) 2003-05-28
EA200200750A1 (en) 2003-02-27
EP1248638B1 (en) 2006-11-08
WO2001049298A3 (en) 2002-04-04
HRP20020573A2 (en) 2003-10-31
YU51802A (en) 2005-06-10
ZA200205415B (en) 2003-10-13
FR2803522A1 (en) 2001-07-13
EP1248638A2 (en) 2002-10-16
AU784656B2 (en) 2006-05-18
EE200200374A (en) 2003-12-15
FR2803522B1 (en) 2004-01-02
AU3183001A (en) 2001-07-16
KR20020069240A (en) 2002-08-29
DE60124373D1 (en) 2006-12-21
PT1248638E (en) 2007-02-28
CN1400905A (en) 2003-03-05
CZ20022303A3 (en) 2002-11-13
NO20023243L (en) 2002-07-04
AR026804A1 (en) 2003-02-26
UA75587C2 (en) 2006-05-15
WO2001049298A2 (en) 2001-07-12
DE60124373T2 (en) 2007-08-30
PL357192A1 (en) 2004-07-26
ATE344671T1 (en) 2006-11-15
BR0107442A (en) 2002-10-08
CA2396178A1 (en) 2001-07-12
MXPA02006672A (en) 2002-09-30
NZ520283A (en) 2004-09-24
ES2275648T3 (en) 2007-06-16
SK9612002A3 (en) 2002-12-03
EA006035B1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
DK1259512T3 (en) Pteridine compounds for the treatment of psoreasis
DK1343773T3 (en) Thiazole derivatives for the treatment of PPAR-related disorders
EE200200172A (en) Compounds for the treatment of ischemia
DK1575597T3 (en) Use of rimexolone for the treatment of eye dryness
DK1292594T3 (en) Quinazoline derivatives for the treatment of tumors
DK1803718T3 (en) 4-Tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
DK1499730T3 (en) Immunoconjugates for the treatment of tumors
DK1448205T3 (en) Combinations for the treatment of immuno-inflammatory diseases
DE50200641D1 (en) locking device
DK1176964T3 (en) Use of ET743 for the treatment of cancer
DK2189162T3 (en) Methods for the treatment of cellular proliferative disorders
DK1411917T3 (en) Carbamate compounds for use in the prevention or treatment of movement disorders
DK1392318T3 (en) 15-keto-prostaglandins for the treatment of drug-induced constipation
DK1345598T3 (en) The use of rosiglitazone in the treatment of psychiatric disorders
DK1344526T3 (en) Means for the prevention / treatment of inflammatory respiratory disorders
DE50202174D1 (en) LOCKING
DE60112580D1 (en) locking device
DK1401424T3 (en) Carbamate compounds for use in the prevention or treatment of psychotic disorders
PT1220858E (en) OXAZINOQUINOLONES UTEIS FOR THE TREATMENT OF VIRAL INFECTIONS
DK1257278T3 (en) Use of mirtazapine for the treatment of sleep disorders
DK1553952T3 (en) Use of dihydroimidazolones in the treatment of epilepsy in dogs
PT1268482E (en) PIRANOINDOIS FOR THE TREATMENT OF GLAUCOMA
DK1248638T3 (en) Use of enoxaparin for the treatment of cerebral ischemia
DE60215425D1 (en) locking device
IS6626A (en) Crystalline treatment agent